Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dilated cardiomyopathy

S C Siu1, M J Sole

  • 1Toronto Hospital, University of Toronto, Ontario, Canada.

Current Opinion in Cardiology
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Dilated cardiomyopathy causes remain debated, with growing recognition of viral and familial factors. Current treatment for dilated cardiomyopathy focuses on managing heart failure symptoms, as specific therapies are lacking.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes incidence and prevalence in Hong Kong, China during 2006-2014.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Cost-Effectiveness of A Short Message Service (Sms) Intervention To Prevent Type 2 Diabetes Among Adults With Impaired Glucose Tolerance.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial.

Diabetes research and clinical practice·2014
Same author

Prevalence of undiagnosed diabetes mellitus and cardiovascular risk factors in Hong Kong professional drivers.

Diabetes research and clinical practice·2012
Same author

Cost implication of team-based structured versus usual care for type 2 diabetic patients with chronic renal disease.

Hong Kong medical journal = Xianggang yi xue za zhi·2011
Same author

Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure.

Heart (British Cardiac Society)·2007

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • The etiology and pathogenesis of dilated cardiomyopathy (DCM) are not fully understood and remain controversial.
  • Increasing evidence highlights the significance of viral infections and familial genetic factors in DCM.
  • Advances in molecular biology are expected to further elucidate these contributing factors.

Purpose of the Study:

  • To review the current understanding of dilated cardiomyopathy etiology and pathogenesis.
  • To discuss diagnostic methods for differentiating cardiac conditions.
  • To summarize the current treatment strategies and future directions for dilated cardiomyopathy management.

Main Methods:

  • Review of existing literature on dilated cardiomyopathy.

Related Experiment Videos

  • Discussion of diagnostic tools including coronary angiography and endomyocardial biopsy.
  • Analysis of clinical trial outcomes for pharmacological interventions.

    • Main Results:

    • Viral and familial etiologies are increasingly recognized in dilated cardiomyopathy.
    • Coronary angiography remains crucial for distinguishing ischemic from non-ischemic DCM.
    • Endomyocardial biopsy has limited utility in diagnosing specific myocardial diseases.
    • No specific treatment for DCM exists; digoxin shows confirmed benefits, while inodilator trials were disappointing.
    • Signal-averaged electrocardiography shows potential for sudden cardiac death risk stratification.

    Conclusions:

    • Treatment for dilated cardiomyopathy currently aligns with general heart failure management.
    • Further research, particularly in molecular biology, is needed to understand DCM causes.
    • Risk stratification tools like signal-averaged electrocardiography may improve patient outcomes.